Glibenclamide–sulfonylurea receptor 1 antagonist alleviates LPS-induced BV2 cell activation through the p38/MAPK pathway

Zhiming Xu(Shanghai Jiao Tong University), Heng‐Li Tian(Shanghai Jiao Tong University)
RSC Advances
January 1, 2017
Cited by 5


Related Papers